search
Back to results

MEOPA Breathing Analgesia for Oocyte Retrieval(KALOVAL) (KALOVAL)

Primary Purpose

Infertility, Pain

Status
Completed
Phase
Phase 4
Locations
France
Study Type
Interventional
Intervention
MEOPA inhalation
xylocaine
Sponsored by
Assistance Publique - Hôpitaux de Paris
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Infertility focused on measuring Oocyte retrieval, pain, surgery, anaesthesiology, Assisted Reproductive Technologies

Eligibility Criteria

18 Years - 42 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • patient requiring a first or second oocyte retrieval procedure for IVR or ICSI after ovarian stimulation by gonadotrophin
  • agreement to participate to this study

Exclusion Criteria:

  • absolute indication for oocyte retrieval with general anesthesia
  • no agreement to participate to this study,
  • painfully known patient-not easy ovarian vaginal accessibility for monitoring or puncture
  • respiratory pathology-chronic liver, kidney pathology, immunodeficiency, -contraindication to the medications used during the protocol

Sites / Locations

  • Hôpital Jean Verdier, service de la médecine de la reproduction, avenue du 14 juillet

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

nitrous oxide

lidocaine

Arm Description

N2O of 50% and 50% O2 MEOPA

Injection solution 1%

Outcomes

Primary Outcome Measures

Pain after oocyte retrieval at + 30, 60 and 120 minutes.

Secondary Outcome Measures

Patients satisfaction at time + 120 minutes.
Patients recommendation at time + 120 minutes. Patients with supplementary analgesics at time + 120 minutes.
Patients with canceled protocol arm attribution during oocyte retrievalART already stated issues Reactive Oxygen Species in retrieved follicular fluid.

Full Information

First Posted
February 6, 2009
Last Updated
September 15, 2012
Sponsor
Assistance Publique - Hôpitaux de Paris
search

1. Study Identification

Unique Protocol Identification Number
NCT00853177
Brief Title
MEOPA Breathing Analgesia for Oocyte Retrieval(KALOVAL)
Acronym
KALOVAL
Official Title
MEOPA Breathing Analgesia vs Local Anesthesia for Oocyte Retrieval in ART: a Prospective, Randomized Controlled Study
Study Type
Interventional

2. Study Status

Record Verification Date
May 2011
Overall Recruitment Status
Completed
Study Start Date
November 2008 (undefined)
Primary Completion Date
January 2011 (Actual)
Study Completion Date
January 2011 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to assess pain, at or after oocyte retrieval, the effectiveness of self-controlled inhalation analgesia by nitrous oxide (N2O of 50% and 50% O2) by the patient compared to a local anesthesia combined with a tablet of 0.5 mg of Alprazolam.
Detailed Description
Oocyte retrieval is a major event during in VITRO-fertilization, with or without sperm micro-injection. Initially done by laparoscopy with general anesthesia, the oocyte collection is now carried out by trans-vaginal controlled ultrasound puncture. This potential painful event, related to trans-vaginal puncture or mechanical movements of the stimulated ovary, requires analgesia or anesthesia. General anesthesia is certainly effective in terms of collected oocytes. It remains, however, a heavy time consumer, with personal risks and distributor of anesthetic agents in blood or follicular fluid. These products could have a deleterious effect on early embryonic development or implantation. Few data are available concerning these risks in the literature. General anesthesia is still essential for pusillanimous patients or for patients with a heavy surgical past. Nitrous oxide is an inhaled gas with properties widely used in obstetric during parturition. It is regularly used during general anesthesia performed for oocyte retrieval. With a gas composed of 50% N2O and 50% O2, its main interest is to provide analgesia in a state of conscious sedation. The effects of nitrous oxide in this form had never been assessed on the clinical or biological Oocyte collection. We conducted a preliminary study to assess pain in patients receiving local anesthesia, according the current protocol. Thus, 44% of patients had severe pain (VAS> 40/100) during or just after transvaginal oocyte retrieval. In our preliminary experience, immediate or distance post-operative pain was high and we plan to evaluate the benefit of analgesia with nitrous oxide in terms of immediate post-operative pain with a prospective, randomized and controlled study as compared with local anesthesia associated to Alprazolam.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Infertility, Pain
Keywords
Oocyte retrieval, pain, surgery, anaesthesiology, Assisted Reproductive Technologies

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
77 (Actual)

8. Arms, Groups, and Interventions

Arm Title
nitrous oxide
Arm Type
Experimental
Arm Description
N2O of 50% and 50% O2 MEOPA
Arm Title
lidocaine
Arm Type
Active Comparator
Arm Description
Injection solution 1%
Intervention Type
Procedure
Intervention Name(s)
MEOPA inhalation
Intervention Description
N2O of 50% and 50% O2
Intervention Type
Procedure
Intervention Name(s)
xylocaine
Other Intervention Name(s)
local anesthesia
Intervention Description
Ampoule-bottle of 20 ml
Primary Outcome Measure Information:
Title
Pain after oocyte retrieval at + 30, 60 and 120 minutes.
Time Frame
immediate (at + 30, 60 and 120 minutes)
Secondary Outcome Measure Information:
Title
Patients satisfaction at time + 120 minutes.
Time Frame
immediate (at + 120 minutes)
Title
Patients recommendation at time + 120 minutes. Patients with supplementary analgesics at time + 120 minutes.
Time Frame
immediate (at time + 120 minutes)
Title
Patients with canceled protocol arm attribution during oocyte retrievalART already stated issues Reactive Oxygen Species in retrieved follicular fluid.
Time Frame
immediate

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
42 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: patient requiring a first or second oocyte retrieval procedure for IVR or ICSI after ovarian stimulation by gonadotrophin agreement to participate to this study Exclusion Criteria: absolute indication for oocyte retrieval with general anesthesia no agreement to participate to this study, painfully known patient-not easy ovarian vaginal accessibility for monitoring or puncture respiratory pathology-chronic liver, kidney pathology, immunodeficiency, -contraindication to the medications used during the protocol
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christophe Poncelet, MD PhD
Organizational Affiliation
Assistance Publique - Hôpitaux de Paris
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hôpital Jean Verdier, service de la médecine de la reproduction, avenue du 14 juillet
City
Bondy
State/Province
Ile de France
ZIP/Postal Code
93143
Country
France

12. IPD Sharing Statement

Citations:
PubMed Identifier
17571915
Citation
Bauer C, Lahjibi-Paulet H, Somme D, Onody P, Saint Jean O, Gisselbrecht M. Tolerability of an equimolar mix of nitrous oxide and oxygen during painful procedures in very elderly patients. Drugs Aging. 2007;24(6):501-7. doi: 10.2165/00002512-200724060-00006.
Results Reference
result
Links:
URL
http://www.ncbi.nlm.nih.gov/pubmed/17571915?ordinalpos=2&itool=Entrez
Description
PubMed

Learn more about this trial

MEOPA Breathing Analgesia for Oocyte Retrieval(KALOVAL)

We'll reach out to this number within 24 hrs